Neoadjuvant chemotherapy for high-risk intrahepatic cholangiocarcinoma - Does pathologic response mean better outcomes?. (2021) - Paez-Arango, N.; Estrella, J.S.; Newhook, T.; Tzeng, C.W.D.; Chun, Y.S.; Lee, S.; Javle, M.; Vauthey, J.N.; Cao, HS Tran